Listen: Can California Lower the Price of Insulin?
California Healthline senior correspondent Angela Hart describes California’s ambitious plan to manufacture generic insulin under the state’s new “CalRx” drug label.
Search
Filter
3,101 - 3,120 of 15,305 Results
-
-
‘American Diagnosis’ Episode 9: Two Indigenous Students Share Their Path to Medicine
A lack of Native physicians means many tribal communities rely on doctors who don’t share their lived experience, culture, or spiritual beliefs. In Episode 9, meet two medical students working to join the ranks of Indigenous physicians.
-
Even Well-Intended Laws Can’t Protect Us From Inaccurate Provider Directories
State and federal laws require health plans to offer accurate lists of participating doctors and facilities, but consumers still struggle to get timely appointments with providers.
-
‘True Cost of Aging’ Index Shows Many Seniors Can’t Afford Basic Necessities
The Elder Index, developed by researchers at the University of Massachusetts-Boston, shows that nearly 5 million older women living alone, 2 million older men living alone, and more than 2 million older couples have incomes that make them economically insecure.
-
Ad Targeting Manchin and AARP Mischaracterizes Medicare Drug-Price Negotiations
The advocacy group American Commitment said empowering Medicare to negotiate drug prices would raid it of billions of dollars. Drug pricing experts say that that’s not the case and that such policies would instead reduce costs for the Medicare program and seniors.
By Victoria Knight and Colleen DeGuzman -
Post-‘Roe,’ People Are Seeking Permanent Sterilizations, and Some Are Being Turned Away
Doctors in states where abortion is or could be banned say more patients are seeking permanent sterilization procedures, but some patients are reporting that providers are unwilling to operate on people of childbearing age.
By Aaron Bolton, MTPR and Ellis Juhlin -
Journalists Reexamine Mental Health Barriers, Gun Control Laws, and Homelessness
KHN and California Healthline staff made the rounds on national and local media this week to discuss their stories. Here’s a collection of their appearances.
-
Three Things About the Abortion Debate That Many People Get Wrong
The commonly repeated myths include arguments that only women who are pregnant are affected by the decision overturning Roe v. Wade, that Democratic lawmakers could have codified abortion protections before, and that Congress can easily get rid of federal laws restricting abortion.
By Julie Rovner -
A Nearly Century-Old Maternity Home for Teens in the South Makes Plans for Expansion
Homes for pregnant girls may seem like a vestige of the past. But they still exist and, in light of the Supreme Court’s recent ruling on abortion, may become more necessary.
-
KHN’s ‘What the Health?’: Drug Price Bill Is a Go in the Senate
Two things happened in Washington this week that were inevitable: President Joe Biden tested positive for covid-19, and the Senate agreed to move forward on a budget bill that includes only a sliver of what Biden hoped it would. Still, the bill to allow Medicare to negotiate some drug prices, cap out-of-pocket drug costs for seniors, and extend temporary subsidies for Affordable Care Act insurance premiums would represent a major step if Democrats can get it across the finish line. Meanwhile, abortion battles continue to escalate around the country, with Texas leading the way in restrictions. Shefali Luthra of The 19th, Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, and Rachel Cohrs of Stat join KHN’s Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Dr. Jack Resneck Jr., the new president of the American Medical Association.
-
Parents Become Drug Developers to Save Their Children’s Lives
Families affected by ultra-rare diseases are starting their own companies to speed the development of treatments for their kids, venturing into territory that traditional drugmakers deem too risky.
-
‘So Rudderless’: A Couple’s Quest for Autism Treatment for Their Son Hits Repeated Obstacles
Amparo and Victor Rios began searching for answers about their son’s development when he didn’t hit some milestones after turning 2. Three years later, they are still trying to get their insurance to pay for expensive therapy to help him.
-
-
Critics Worry Government Surveillance of HIV May Hurt More Than It Helps
Some people living with HIV and some state health officials are raising concerns about part of the federal effort to end the HIV epidemic: a new technology that analyzes blood samples to find emerging outbreaks. The critics say it’s too invasive and stigmatizing and might not be more effective than older public health approaches.
-
No-Bid Medicaid Contract for Kaiser Permanente Is Now California Law, but Key Details Are Missing
California Gov. Gavin Newsom signed a bill last month that authorizes a statewide Medicaid contract for HMO giant Kaiser Permanente. But details still need to be worked out in a memorandum of understanding.
-
Fighting Monkeypox, Sexual Health Clinics Are Underfunded and Ill-Equipped
Sexual health clinics are scrambling to properly track, test, and treat hundreds of monkeypox patients. So far, it isn’t going well.
By Liz Szabo and Lauren Weber -
In Some States, Voters Will Get to Decide the Future of Abortion Rights
Measures to enshrine the right to abortion in the state constitution will be on the ballot in California and Vermont this fall. Abortion-rights advocates in Michigan are hoping their state will follow suit.
-
FTC Official: Antitrust Push in Health Care Must Focus on a Merger’s ‘Human Impact’
Mark Seidman, an assistant director in the Federal Trade Commission’s Bureau of Competition, talks with KHN about efforts to police consolidation among hospitals and other health care providers.
By Harris Meyer -
Boost Now or Wait? Many Wonder How Best to Ride Out Covid’s Next Wave
As the country faces a rise in new infections driven by the omicron BA.5 subvariant of the coronavirus, about 70% of people 50 and older who got a first covid-19 booster shot haven't received the recommended second one, according to the Centers for Disease Control and Prevention. Many undervaccinated Americans have lost interest, and others aren’t sure whether to get boosted again now or wait for vaccines reformulated to target newer strains of the virus.
By Sam Whitehead and Arthur Allen -
Conservative Blocs Unleash Litigation to Curb Public Health Powers
Spurred on by opposition to pandemic-related health mandates, a coalition of religious liberty groups, conservative think tanks, and Republican state attorneys general has filed a cascade of litigation seeking to rein in the powers of public health authorities.